Supplementary methods

Genome-editing with CRISPR/Cas9
For the genome-editing of RAW 264.7 cells with CRISPR/Cas9, the gRNAs for generation of LRRK2 P755L, R1628P and KO cell lines were synthesized by using GeneArt precision gRNA synthesis kit from Thermo Fisher according to the manufacturer's instruction (See SI Appendix, table S6). On the day prior to transfection, RAW264.7 cells were split into a new flask with fresh growth medium such that the cells reach 70-90% confluency the following day. On the day of electroporation, cells were washed with PBS and treated with 0.25% trypsin-EDTA for 8-10 min at 37°C. After neutralization of trypsin, 1 x 10 5 cells per transfection were transferred to a 1.5 ml microcentrifuge tube. In parallel with the preparation of cells for electroporation, 2µg
Cas9 protein and 400 ng gRNA were mixed in 10 l of resuspension buffer R and incubated at room temperature for 10 min to form stable Cas9-gRNA complex. Prepared cells were re-suspended in the buffer R (provided in Neon transfection system 10 l kit, Thermo Fisher) containing the Cas9-gRNA complex and 50 pmol of donor homologydirected recombination (HDR) templates was added (See SI Appendix , table S6). The cell mixture was transferred into a 10 l Neon tip with Neon pipette and electroporation was performed using the following parameters: pulse voltage 1680 V, pulse width 20 ms and pulse number 1. After electroporation, cells from two Neon tips were transferred to 12-well plates and cultured on growth media for 4 days. Next, the cells were counted and serially diluted to 2 x 10 4 cells/ml, 5 x 10 2 cells/ml and 5 cells/ml. A volume of 200 µl of 5 cells/ml suspension was dispensed to each well of 96-well plates. Plates were incubated at 37°C in a 5% CO2. Genomic DNA was isolated from single cell colonies. The donor target region of single clones was Sanger sequenced to check incorporation of the designed variants. Selected RAW264.7 cells were maintained in Dulbecco's Modified Eagle (DMEM) medium supplemented with 10% fetal bovine serum and 1% streptomycin-penicillin, and incubated in a humidified atmosphere containing 5% CO2 at 37°C. The cells were passaged every 3 days.
Growth of mycobacteria
BCG Russia cultures were maintained in middlebrook 7H9 medium supplemented with 10% ADC, 0.1% Tween 80, and 0.2% glycerol at 37°C on a roller. On the day of infection to break up large aggregates into single cells, re-suspended BCG bacilli were subjected to water bath sonication for 20s x 5 times, followed by passing the BCG through a 22 1/2-G needle 8 times. Any remaining clumps were removed by slow speed centrifugation (100xg for 5 min). Bacterial load was determined by plating serial 10-fold dilutions of BCG and CFUs were estimated from colony counts after at least 3 weeks of incubation. The Thai-53 isolate M. leprae was harvested from both hind foot pads of athymic nude mice (Envigo, USA) inoculated 5-7 months previously with 3 x 10 7 bacilli.
The harvested bacilli were enumerated by direct count according to Shepard's method and held overnight at 4 -8 o C pending quality control testing for contamination and viability. Viability of the M. leprae suspension was measured by determining the rate of 14C-palmitic acid oxidation to 14 CO2 by radiorespirometry as described previously (1) . A 24hr count of at least 6000cpm was considered viable. Freshly harvested bacilli were always employed in experiments within 24-48 hrs of harvest.
Western Blot analysis
Total cellular lysates were resolved on a 4% to 12% Tris-Glycine gel (Bio-Rad) and electrophoretically transferred to polyvinylidene difluoride membranes (Bio-Rad).
The membranes were blocked with 5% BSA in TBS-T (Tris-buffered saline-0.1% Tween 20) for 1 h at room temperature, a procedure followed by incubation with primary antibodies overnight at 4C. A rabbit monoclonal antibody against LRRK2 (Abcam) was used at 1:1,000 dilution. A mouse anti-GAPDH monoclonal antibody (Thermo Fisher) was used at a 1:10,000 dilution. Upon extensive washing, the membrane was developed with enhanced chemiluminescence detection reagents (Bio-Rad), followed by imaging using a ChemiDoc Touch imaging system (Bio-Rad). Experiments were performed in triplicates.
Database curation
The predicted impact at the protein level for nonsynonymous variants described in our study was assessed in five databases as in previous studies (2, 3) . The algorithms used for the predictions were PolyPhen2 HumDiv and HumVar (4), SIFT (5), LRT (6), Mutation Taster (7) and CADD (8) . To evaluate if rare variants associated with T1R were also reported in PD cases, we used the PDmutDB (http://www.molgen.vibua.be/PDMutDB/) (9) and the Leiden Open Variation Database (LOVD) for Parkinson's Disease (http://grenada.lumc.nl/LOVD2/TPI/home.php) (10) . To evaluate the frequency of the mutations of the targeted genes we used the dbSNP v147 (https://www.ncbi.nlm.nih.gov/snp) (11) and gnomAD (http://gnomad.broadinstitute.org/) (12) databases.
Cloning and purification of recombinant human Parkin
The human Parkin coding DNA sequence was codon-optimized for expression in E. coli (GeneArt, Life Technologies). The gene was cloned in the pGEX-6p1 plasmid with the BamH1 and Xho1 restriction sites. Mutations were inserted using the single-site directed mutagenesis kit (Agilent). The GST-fusion proteins were expressed in BL21 DE3 cell lines (NEB) in Luria Broth at 37°C up to an O.D of 1.0, after which they were incubated at 16°C, induced with 100 μM IPTG, at 16°C for 18 h. Cells were harvested and lysed via sonication in lysis buffer (50 mM Tris, 150 mM NaCl, 3 mM DTT, 0.1 mg/ml lysozyme, 25 lg/ml DNase I, 5 mM MgSO4, and 0.5% Tween at pH 8.0, and a cocktail of EDTAfree protease inhibitor from Roche). Glutathione-sepharose resin was used to bind GSTtagged protein in binding buffer (50 mM Tris, 150 mM NaCl, 3 mM DTT pH 8.0) for 60 min on a rotating platform at 4°C. After washing with the binding buffer, the protein was eluted with elution buffer (50 mM Tris, 150 mM NaCl, 20 mM glutathione, and 3 mM DTT pH, 8.0) and concentrated using Amicon-Ultra concentrators (10,000 M.W. cut-off; EMD Millipore). To cleave the GST tag, 3C protease (1:50 protease-to-substrate ratio) was incubated with the protein overnight at 4°C. The protein was further purified by sizeexclusion chromatography in binding buffer using a Superdex S200 column connected in series with a GST trap 4B (GE Healthcare) to remove GST. The protein was concentrated to 2-4 mg/mL and the concentration was estimated by UV spectroscopy using extinction coefficients calculated from the amino acid composition.
Ubiquitination assay
Ubiquitination assays were performed in two steps in a buffer containing 50 mM TrisHCl pH 7.5, 120 mM NaCl, 1 mM DTT and 10 mM MgCl2. In step A, Parkin (2 μM) was mixed 5 mM ATP, 50 μM ubiquitin and 0.1 μM TcPINK1121-570, purified as described previously (13) . The mix was incubated 15 min at 37°C to phosphorylate Parkin and ubiquitin. In step B, 50 nM human His6-E1 and 2 μM His6-UbcH7 (see Trempe et al. 2013 ) were added to the mix and incubated for an additional 15 min at 37°C. Reactions were stopped with the addition of SDS-PAGE sample buffer containing 50 mM DTT and resolved by gel electrophoresis. Images were obtained using the stainfree UV system (Biorad) and colloidal Coomassie Blue G-250 staining.
Phosphorylation assay
Parkin (20 μM or 1 mg/mL) was mixed 5 mM ATP, 20 μM ubiquitin and 1 μM TcPINK1121-570. The mix was incubated 15 min at 37°C and the reaction was stopped with 1% formic acid for direct injection of 2 μg on the mass spectrometer, as described above.
Supplementary figures
Fig. S1. TNF production in response to BCG infection
RAW cells were challenge with BCG for 6 hours (panel A) and 24 hours (Panel B) and TNF production was estimated by ELISA. The plots represent the combined results from two independent experiments in duplicate and triplicate, respectively. P values were calculated using one-way ANOVA with Tukey correction. Table S1 . Epidemiological data of the studied sample.
Supplementary tables
T1R affected T1R free
237
Age at leprosy diagnosis No PD variant 1 214
Total
6* 287
Parkin mutated residues observed in Parkinson's disease cases were extracted from the PDmutDB and LOVD database. Mutations in Parkin residues were accounted only once even if different amino acid substitutions were cataloged for a given position.
Substitutions in Parkin residues 167 and 380 were not included in the analyses due to their high frequency in the general population. A hypergeometric test was used to investigate the pleiotropic enrichment. *If the novel variant observed in a T1R case by our study was to be included as "No PD" variant the pleiotropic effect would still remain highly significant (p = 8.7 x10 -4 ). Table S6 . Oligonucleotides used in the CRISPR/Cas9 constructs. 
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